$4.38 Billion in Sales Expected for Tenet Healthcare Corp (THC) This Quarter

Brokerages expect Tenet Healthcare Corp (NYSE:THC) to announce $4.38 billion in sales for the current quarter, Zacks Investment Research reports. Nine analysts have made estimates for Tenet Healthcare’s earnings. The lowest sales estimate is $4.31 billion and the highest is $4.43 billion. Tenet Healthcare reported sales of $4.59 billion in the same quarter last year, which indicates a negative year-over-year growth rate of 4.6%. The business is expected to report its next earnings results after the market closes on Monday, November 5th.

On average, analysts expect that Tenet Healthcare will report full-year sales of $18.12 billion for the current financial year, with estimates ranging from $18.08 billion to $18.19 billion. For the next year, analysts forecast that the company will post sales of $17.89 billion, with estimates ranging from $16.95 billion to $18.39 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that cover Tenet Healthcare.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Monday, August 6th. The company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.25 by $0.24. The business had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.57 billion. Tenet Healthcare had a positive return on equity of 38.91% and a negative net margin of 2.51%. Tenet Healthcare’s quarterly revenue was down 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.17) EPS.

THC has been the topic of a number of research reports. Zacks Investment Research lowered Tenet Healthcare from a “buy” rating to a “hold” rating in a research report on Monday, August 13th. JPMorgan Chase & Co. boosted their price objective on Tenet Healthcare from $22.00 to $28.00 and gave the stock an “underweight” rating in a research report on Friday, August 10th. ValuEngine lowered Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 27th. SunTrust Banks restated a “hold” rating and set a $35.00 price objective on shares of Tenet Healthcare in a research report on Wednesday, August 8th. Finally, Jefferies Financial Group lowered Tenet Healthcare from a “buy” rating to a “hold” rating and boosted their price objective for the stock from $28.00 to $38.00 in a research report on Friday, June 29th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $30.80.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Assetmark Inc. grew its position in shares of Tenet Healthcare by 45.8% in the 2nd quarter. Assetmark Inc. now owns 5,093 shares of the company’s stock valued at $171,000 after buying an additional 1,601 shares during the last quarter. Arizona State Retirement System grew its position in shares of Tenet Healthcare by 3.6% in the 2nd quarter. Arizona State Retirement System now owns 56,681 shares of the company’s stock valued at $1,903,000 after buying an additional 1,959 shares during the last quarter. Amalgamated Bank grew its position in shares of Tenet Healthcare by 16.9% in the 2nd quarter. Amalgamated Bank now owns 13,634 shares of the company’s stock valued at $458,000 after buying an additional 1,970 shares during the last quarter. Metropolitan Life Insurance Co. NY grew its position in shares of Tenet Healthcare by 5.4% in the 2nd quarter. Metropolitan Life Insurance Co. NY now owns 48,312 shares of the company’s stock valued at $1,622,000 after buying an additional 2,470 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Tenet Healthcare by 48.5% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,267 shares of the company’s stock valued at $278,000 after buying an additional 2,700 shares during the last quarter.

THC stock traded down $0.04 during midday trading on Monday, reaching $25.39. 1,156,329 shares of the stock were exchanged, compared to its average volume of 1,912,491. The firm has a market capitalization of $2.91 billion, a P/E ratio of 31.35, a P/E/G ratio of 1.27 and a beta of 0.92. Tenet Healthcare has a 52 week low of $12.25 and a 52 week high of $39.74. The company has a quick ratio of 1.01, a current ratio of 1.08 and a debt-to-equity ratio of 24.66.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company. It operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The company's general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Featured Article: What are the risks of holding treasury bonds?

Get a free copy of the Zacks research report on Tenet Healthcare (THC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply